Target intelligence / Profile preview

Amyloid precursor protein processing pathway (APP processing pathway)

Target
APP processing pathway
Molecular classification
Enzyme, Protease, Pathway
01

Overview

The Amyloid precursor protein (APP) processing pathway, also known as the Aβ-related enzymes and processing axis, is a complex proteolytic system that regulates the production and degradation of amyloid-beta (Aβ) peptides. This axis involves the competing activities of α-secretase (ADAM10), which initiates the non-amyloidogenic pathway, and β-secretase (BACE1) followed by γ-secretase, which drive the amyloidogenic production of neurotoxic Aβ species. The balance of this axis is further maintained by Aβ-degrading enzymes such as neprilysin and insulin-degrading enzyme, which clear Aβ from the brain. Dysregulation of this processing axis is a central driver of Alzheimer's disease pathology, leading to the accumulation of Aβ plaques and subsequent neurodegeneration. Therapeutic strategies targeting this axis have primarily focused on BACE1 and γ-secretase inhibition, though these have faced significant clinical hurdles due to off-target effects and safety concerns. Recent research also explores the activation of α-secretase and the enhancement of degrading enzymes to restore Aβ homeostasis.

Other names
Aβ-related enzymes and processing axisAmyloid-beta processing axisAmyloidogenic pathwayNon-amyloidogenic pathwaySecretase processing of APPAβ metabolic pathway
02

Mechanism of action

Modulation of the proteolytic cleavage of amyloid precursor protein (APP) by inhibiting β-secretase (BACE1) or γ-secretase to reduce Aβ production, or by activating α-secretase (ADAM10) to promote the non-amyloidogenic pathway. It also includes the clearance of Aβ products via enzymatic degradation or antibody-mediated removal.

03

Biological functions

Protein processingProteolysisAmyloidogenesisSignal transduction
04

Disease associations

Alzheimer's diseaseCerebral amyloid angiopathyNeurodegenerative disease
05

Safety considerations

Notch signaling interferenceGastrointestinal toxicitySkin cancer (squamous cell carcinoma)Paradoxical cognitive worseningHypopigmentationWeight lossAmyloid-Related Imaging Abnormalities (ARIA)
06

Interacting drugs

Verubecestat

10 more in the full profile.

07

Biomarkers

CSF Aβ42/Aβ40 ratioAmyloid PET imagingSoluble APP alpha (sAPPα)Soluble APP beta (sAPPβ)BACE1 activity levels

Beyond the preview

Go deeper on Amyloid precursor protein processing pathway (APP processing pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid precursor protein processing pathway (APP processing pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call